Low-temperature plasma sterilizer market seen reaching $2.48 billion by 2030

The low-temperature plasma sterilizer market is projected to rise from $1.49 billion in 2025 to $2.48 billion by 2030, according to a new report from The Business Research Company. Growth is being driven by infection-control needs, rising surgical volume and broader use of sterilization for heat-sensitive medical devices.

Why it matters: - Low-temperature plasma sterilizers help healthcare facilities disinfect delicate instruments that cannot handle steam or high heat. - The market's growth reflects stronger infection-control standards and rising demand for safer reuse of sensitive medical equipment. - The technology also matters outside hospitals, with growing use expected in pharmaceutical packaging, laboratories and mobile care settings.

What happened: - The Business Research Company released its Low Temperature Plasma Sterilizer Market Report 2026, covering market size, trends and a global forecast through 2035. - The market is projected to grow from $1.49 billion in 2025 to $1.65 billion in 2026. - The report forecasts the market will reach $2.48 billion by 2030. - The forecast implies a 10.7% compound annual growth rate through the period. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - A low-temperature plasma sterilizer uses hydrogen peroxide vapor and low-temperature plasma, an ionized gas, to sterilize instruments. - The process typically runs below 60°C, making it suitable for heat- and moisture-sensitive equipment. - The technology eliminates bacteria, viruses and spores. - The method is designed to leave no harmful residue. - The report links historical growth to traditional steam-sterilizer dependence, limited awareness of low-temperature options, expanding hospital and clinic infrastructure, more surgical and dental procedures, and tighter equipment-sterilization rules. - The report points to innovations in cold plasma and hydrogen peroxide sterilization, smart hospital integration, and wider use in homecare and mobile healthcare as future drivers. - The report also highlights demand for residue-free and rapid sterilization processes. - The market coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, a company scoring matrix, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables. - The report is available through a free sample download and a full report view.

Between the lines: - Rising healthcare-associated infections are a major demand driver because sterilization failures can directly affect patient safety and device reuse. - The report cites UK Health Security Agency data showing MRSA bacteraemia cases in the UK rose from 1.7 to 1.8 cases per 100,000 population between the first quarters of 2024 and 2025. - That kind of pressure tends to favor technologies that can sterilize sensitive tools faster and without residue. - The forecast also suggests procurement may shift toward systems that fit connected hospitals and outpatient care workflows.

What's next: - The market is expected to keep expanding through 2030 as infection-prevention priorities and instrument complexity increase. - Adoption should accelerate in settings that need low-temperature, rapid-cycle sterilization for sensitive devices. - Growth may be strongest in Asia-Pacific as healthcare infrastructure and technology adoption broaden.